Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityNo recent work listed

Muxing Kang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6743-5541; OpenAlex author ID A5111047635. Sources: OpenAlex.

Their work

Papers
13 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2012: 3 papers · 2013: 1 paper · 2014: none · 2015: none · 2016: 2 papers · 2017: 2 papers · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 13

  1. VNN1 overexpression in pancreatic cancer cells inhibits paraneoplastic islet function by increasing oxidative stress and inducing β‑cell dedifferentiation. First author DOI 10.3892/or.2023.8557↗
  2. Metformin-Induced Stromal Depletion to Enhance the Penetration of Gemcitabine-Loaded Magnetic Nanoparticles for Pancreatic Cancer Targeted Therapy. Co-author DOI 10.1021/jacs.0c00650↗
  3. Pancreatic cancer-derived exosomes promoted pancreatic stellate cells recruitment by pancreatic cancer. Co-author DOI 10.7150/jca.27590↗
  4. Thymidylate synthase prompts metastatic progression through the dTMP associated EMT process in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2018.01.026↗
  5. Pancreatic cancer-derived exosomes suppress the production of GIP and GLP-1 from STC-1 cells in vitro by down-regulating the PCSK1/3. Co-author DOI 10.1016/j.canlet.2018.05.027↗
  6. Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway. Co-author DOI 10.1038/s41598-017-05541-4↗
  7. SOX7 expression correlates with better prognosis in pancreatic cancer patients and is negatively related to pancreatic cancer associated diabetes. First author PMID 31966461↗
  8. VNN1, a potential biomarker for pancreatic cancer-associated new-onset diabetes, aggravates paraneoplastic islet dysfunction by increasing oxidative stress. Co-author DOI 10.1016/j.canlet.2015.12.031↗
  9. Deguelin inhibits proliferation and migration of human pancreatic cancer cells in vitro targeting hedgehog pathway. Co-author DOI 10.3892/ol.2016.4928↗
  10. Delta like ligand 4 induces impaired chemo-drug delivery and enhanced chemoresistance in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2012.11.015↗
  11. DJ-1, a novel biomarker and a selected target gene for overcoming chemoresistance in pancreatic cancer. First author DOI 10.1007/s00432-012-1205-3↗
  12. Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer. Co-author DOI 10.3892/ol.2012.783↗
  13. MACC1: A potential molecule associated with pancreatic cancer metastasis and chemoresistance. First author DOI 10.3892/ol.2012.784↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yulian Wu · 10 shared papers, 2012–2019 · strength 0.57
  2. Qingqu Guo · 6 shared papers, 2012–2023 · strength 0.47
  3. Wenjie Qin · 1 shared paper, 2023 · strength 0.24
  4. Yizhao Zhou · 3 shared papers, 2018–2019 · strength 0.23
  5. Pengping Li · 3 shared papers, 2018–2019 · strength 0.23
  6. Lantian Wang · 3 shared papers, 2017–2018 · strength 0.21
  7. Wen Ling Zheng · 3 shared papers, 2016–2017 · strength 0.19
  8. Wenjie Qin · 3 shared papers, 2016–2017 · strength 0.19
  9. Liming Zhou · 1 shared paper, 2017 · strength 0.15
  10. Yuefeng Zhang · 2 shared papers, 2017–2018 · strength 0.14
  11. Jian Ji · 1 shared paper, 2020 · strength 0.12
  12. Haijie Han · 1 shared paper, 2020 · strength 0.12
  13. Mingyuan Gao · 1 shared paper, 2020 · strength 0.12
  14. Xiaohui Chen · 1 shared paper, 2020 · strength 0.12
  15. Bo Zhang · 3 shared papers, 2012 · strength 0.11
  16. Wenjie Lu · 2 shared papers, 2012–2018 · strength 0.10
  17. Yue‐Feng Zhang · 1 shared paper, 2019 · strength 0.09
  18. Xiaoman He · 1 shared paper, 2019 · strength 0.09
  19. Bin Juan Yang · 1 shared paper, 2018 · strength 0.07
  20. Ying Chen · 2 shared papers, 2012 · strength 0.07
  21. Qing Chen · 1 shared paper, 2018 · strength 0.07
  22. Chao Richard Li · 1 shared paper, 2016 · strength 0.07
  23. Gang Wang · 1 shared paper, 2012 · strength 0.04
  24. Xin Dong · 1 shared paper, 2013 · strength 0.03
  25. Bin Xu · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.